Schonfeld Strategic Advisors’s MoonLake Immunotherapeutics MLTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$535K	Sell	28,682 -293,579	-91%	-$4.86M	﹤0.01%	1355
2025 Q4	$4.25M	Sell	322,261 -643,144	-67%	-$7.59M	0.02%	599
2025 Q3	$6.92M	Buy	+965,405	New	+$50.3M	0.04%	463
2025 Q2	–	Sell	-10,669	Closed	-$417K	–	2349
2025 Q1	$417K	Buy	10,669 +6,758	+173%	+$291K	﹤0.01%	1658
2024 Q4	$212K	Sell	3,911 -82,864	-95%	-$4.23M	﹤0.01%	1746
2024 Q3	$4.38M	Sell	86,775 -29,663	-25%	-$1.39M	0.03%	594
2024 Q2	$5.12M	Sell	116,438 -27,012	-19%	-$1.14M	0.03%	545
2024 Q1	$7.21M	Sell	143,450 -16,950	-11%	-$919K	0.05%	500
2023 Q4	$9.69M	Sell	160,400 -180,300	-53%	-$9.29M	0.06%	361
2023 Q3	$19.4M	Buy	340,700 +222,740	+189%	+$12.3M	0.15%	189
2023 Q2	$6.02M	Buy	117,960 +80,760	+217%	+$2.17M	0.05%	447
2023 Q1	$796K	Buy	+37,200	New	+$625K	0.01%	1028
2022 Q1	–	Sell	-50,106	Closed	-$496K	–	2788
2021 Q4	$496K	Buy	+50,106	New	+$498K	﹤0.01%	1268